RecruitingPhase 3NCT05018221

Better Evidence and Translation for Calciphylaxis

Studying Calciphylaxis

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Sydney
Principal Investigator: Meg Jardine
University of Sydney
Intervention: Vitamin K1(drug)
Enrollment: 350 enrolled
Eligibility: 18 years · All sexes
Timeline: 2021 – 2029

Study locations (21)

Concord Repatriation General Hospital, Concord, New South Wales, Australia
St George Hospital, Kogarah, New South Wales, Australia
Liverpool Hospital, Liverpool, New South Wales, Australia
John Hunter Hospital, New Lambton Heights, New South Wales, Australia
Westmead Hospital, Westmead, New South Wales, Australia
Sunshine Coast Hospital and Health Service, Birtinya, Queensland, Australia
Princess Alexandra Hospital, Brisbane, Queensland, Australia
Bundaberg Base Hospital, Bundaberg, Queensland, Australia
Cairns Hospital, Cairns, Queensland, Australia
Townsville Hospital, Douglas, Queensland, Australia
Ipswich Hospital, Ipswich, Queensland, Australia
Royal Melbourne Hospital, Melbourne, Victoria, Australia
Sunshine Hospital (Western Health), St Albans, Victoria, Australia
Royal Perth Hospital, Perth, Western Australia, Australia
Royal Adelaide Hospital, Adelaide, Australia
+6 more locations on ClinicalTrials.gov

Collaborators

Australasian Kidney Trials Network · Northern Care Alliance NHS Foundation Trust · Waitemata District Health Board · Vantive Health LLC · Berry Consultants

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05018221 on ClinicalTrials.gov

Other trials for Calciphylaxis

Additional recruiting or active studies for the same condition.

See all trials for Calciphylaxis →

← Back to all trials